Old Web
English
Sign In
Acemap
>
authorDetail
>
L. C. DeMarco
L. C. DeMarco
Regimen
Phases of clinical research
Medicine
FOLFIRI
Bevacizumab
2
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pooled safety results from SPIRITT: A multicenter, open-label, randomized, phase II study of FOLFIRI with panitumumab (pmab) or bevacizumab (bev) as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC).
2011
Journal of Clinical Oncology
J.R. Hecht
Shaker R. Dakhil
Mansoor N. Saleh
Bilal Piperdi
Mika Cline-Burkhardt
D. M. Kocs
L. C. DeMarco
L. Chen
K. Krishnan
Allen Lee Cohn
Show All
Source
Cite
Save
Citations (2)
Randomized phase II study of the efficacy and safety of gemcitabine plus TH-302 versus gemcitabine alone in previously untreated patients with advanced pancreatic cancer.
2011
Journal of Clinical Oncology
Mitesh J. Borad
Darren Sigal
Hope E. Uronis
Joe Stephenson
Nathan Bahary
Mark U. Rarick
L. C. DeMarco
T. J. Finnegan
E. G. Chiorean
David P. Ryan
Allen Lee Cohn
Brian Ulrich
V. C. Harish
E. N. Anderes
Wen Wee Ma
P. P. Yu
F. Sinicrope
Clarence Eng
U. K. Sunkara
Shantan G. Reddy
Show All
Source
Cite
Save
Citations (5)
1